That is very important, due to the fact that the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (second wave). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're developed to do. This was a breakthrough almost nobody observed. However it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of investment chances in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back possibly significantly prior to going greater - future report review. I've been covering bitcoin for a long period of time now. One of the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly educating readers. However that's not the big question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown biotech stocks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many great personal companies on the verge of hitting the public markets And I've been working on a new method for you to invest even prior to these business go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Diary. Routine Journal readers know that tech isn't our normal beat (tech predictions). And when it comes to tech investing, we leave it to the experts. Thankfully, we have a number of such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (genetic sequencing companies jeff brown). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big photo and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and much more. These patterns are experiencing rapid growth and producing incredible opportunities for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown. However despite what many readers may think, this is a trend that's just starting. Although the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (genetic sequencer stock jeff brown). Losing two months of manufacturing and sales actually affects the number of 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million units is remarkable. More significantly, the delays triggered by the pandemic produced a heap of pent-up need. And that demand is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G gadgets will be shipped in 2021 - exponential growth. Which's not my only 5G prediction When I've discussed 5G in the past, I've described its three different stages.
In Stage 2, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Phase Three, 5G services start to be used (future report). That's when we start to see applications working on 5G networks. Consider things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage 3 by this summer season. This begins something of a virtuous cycle: The majority of people don't truly care about the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of extraordinary applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment chances going forward will be massive. Stepping away from 5G, the next essential technology I anticipate in 2021 is CRISPR genetic editing. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were actually just three business operating in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering incredible returns. This entire market is successfully a greenfield chance.
There's room for numerous companies to exist in this space. united states. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software can accurately predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is necessary due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental procedure. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however a number of drug therapies produced utilizing this innovation. This was among those advancements that nearly no one observed. But it's going to have extensive implications for treating illness. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back possibly substantially prior to going higher. I've been covering bitcoin for a very long time now. Among the very first research study reports I ever published was on bitcoin - jeff brown stock predictions 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. white house. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information is up to date as of February 2021, but we might not individually verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional point of view on the marketplace. He's always on the hunt for new opportunities, and he shares many of his finest choices in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively anticipated a few of the greatest financial events of the previous twenty years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it best whenever, but Jeff Brown's accurate predictions have actually made him legions of dedicated fans. That says a lot about his capability. The Near Future Report is released by Brownstone Research, a popular monetary research publisher. Brownstone Research study uses several research study services with a wide range of specializations - jeff brown predictions for 2021.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - future report review. On its website, Brownstone states its objective is to supply retail financiers with professional-grade research study: "For too long, the finest financial investment research has actually not been offered to specific financiers. It has actually been generally booked for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown investment prediction. The mission of Brownstone Research study is to make that sort of exclusive research offered to any investors looking to get an edge in the markets. The goal is basic to provide unique and rewarding financial investment research found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the company's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. longtime readers. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown believes S.A.V. jeff brown genetic sequencer stock. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two cutting-edge technologies: expert system and electric automobiles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the automobile market's Holy Grail. As you understand, electric cars and self-driving vehicle stocks have actually been huge this year, however the Wall Street machine has approved hype without much tangible result. In spite of an extreme boost in competitors over the previous few years, Brown still thinks Musk has the best opportunity of putting all of it together.
tech might be the magic string that connects all of it together. S.A.V. means Shared Autonomous Vehicle, and it might be the future of transport. Basically, this technology would permit you to lease your cars and truck as a self-governing, self-driving taxi when you're not using it. You simply get out of the vehicle and press a button on an app that informs the car to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a substantial chunk of the revenues. It sounds outrageous, but it might be closed than you believe.